Scinai Immunotherapeutics (SCNI) Preferred Shares (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Preferred Shares for 2 consecutive years, with $5.6 million as the latest value for Q4 2025.
- Quarterly Preferred Shares changed 0.0% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $5.6 million for FY2025, 0.0% changed from the prior year.
- Preferred Shares hit $5.6 million in Q4 2025 for Scinai Immunotherapeutics, roughly flat from $5.6 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $5.6 million in Q4 2024 to a low of $5.6 million in Q4 2024.